FX-LEARN: Language Learning in Children with FXS

/, Research/FX-LEARN: Language Learning in Children with FXS

FX-LEARN: Language Learning in Children with FXS

Are you interested in a language intervention that may help your child with Fragile X Syndrome communicate better?

Dr. Elizabeth Berry-Kravis at Rush University is the Protocol Principal Investigator and is leading a national study, NN107 FX-LEARN. There are two purposes to the study. First, to find out if the drug AFQ056, made by the pharmaceutical company Novartis, is safe and has beneficial effects on learning in children who have Fragile X syndrome (FXS).  Second, to find out if a structured language intervention can help children with Fragile X syndrome communicate better.

The trial will be a multi-center, phase II randomized, double-blind placebo-controlled parallel-group flexible-dose forced-titration study that will use a novel design to address the impact of AFQ056 on language learning in 3- to 6-year-old children with FXS. Subjects will be in the study a total of 21 months (Screening and 12 months placebo-controlled treatment, 8 months open-label extension, 1 month follow up after final assessment visit). The study is conducted by the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT). The National Institute of Neurological Disorders and Stroke (NINDS), a division of the National Institutes of Health (NIH), is supporting this trial.

Q: Who can participate?

Children ages 3-6:

  • With Fragile X Syndrome.
  • Who use intentional acts of communication (including words, gestures, and augmentative communication devices).

Q: What does the study involve?

  • 15 study visits over 21 months.
  • Behavioral and language assessments, medical history, a physical exam, parent questionnaires, and blood and urine sampling.
  • Weekly video conferencing sessions in your home to learn strategies to help your child with language.
  • Child will be randomized to either AFQ056 or placebo.

Q: What else can I expect?

  • Families receive instruction and feedback from expert speech and language pathologists.
  • Travel reimbursement is available.

Q: How can I learn more before applying?

NFXF FX-LEARN Q&A Webinar with Dr. Berry-Kravis

Q: Where can I participate?

  • The following clinical sites are currently enrolling participants. Use the contact form on this page to be connected with the coordinator, Katie Friedmann, RN, who will work to get you enrolled, if eligible, at the most convenient and available site.
Boston Children’s Hospital University of Cincinnati Medical Center
Children’s Hospital of Philadelphia University of Colorado – Denver
Children’s National Medical Center (DC) University of Pittsburgh
Columbia University Medical Center (NY) University of Texas Soutdwestern Medical Center
Emory University (GA) Vanderbilt University (TN)
Nationwide Children’s Hospital (OH) Washington University in Saint Louis
Rush University (IL) Yale University (CT)
University of California at Davis

If you’d like to learn more or apply for this opportunity, please fill out the form to send your contact information to the study coordinators.



If you arrived on this page through a MyFXResearch Portal search, you can close this window and return to your filtered results. Or start a new search here.
View More Opportunities

View All

Metformin in Individuals with Fragile X Syndrome

We have preliminary evidence that metformin, a common type 2 diabetes medication, is beneficial for language, cognition, and behavior in both children and adults with Fragile X Syndrome.

Describing Anxiety for People with Fragile X Syndrome

A survey to measure levels of behavior. When someone with FXS is experiencing anxiety, describe what you see and hear, and how the experience impacts your/their quality of life.

Visual Perception Study

Our research is looking at how you see and remember the visual world, and how attention changes what we see. We hope our findings will provide a better understanding of the differences in vision and attention occurring in autism.

Purdue University: Brain and Behavior Study

Our goal is to better understand the different mechanisms within the brain that contribute to the development of psychiatric conditions, including depression, so we can establish better prevention and intervention efforts within this population.

Study of Reproductive Decision Making

This is a voluntary, and completely anonymous, research survey for women and men who have had a child, or at risk of having a child, with a genetic childhood disorder.​​

Study on Language Development in Young Adults with Fragile X Syndrome

The goal of the study is to learn more about how certain abilities, types of experiences, and biology affect language abilities in adulthood for both males and females with Fragile X syndrome.

By | 2019-07-16T16:07:20+00:00 Mar 27, 2019|Opportunities for families, Research|Comments Off on FX-LEARN: Language Learning in Children with FXS